Journal
TUBERCULOSIS
Volume 105, Issue -, Pages 53-59Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2017.04.009
Keywords
Bovine tuberculosis; Mycobacterium bovis; Interleukin 1 beta; Interferon-gamma; Flow cytometry
Categories
Funding
- Science and Technology Development Fund [2081]
- Research Enhancement Program (ALEX REP), Alexandria University Research Fund (AURF)
Ask authors/readers for more resources
Bovine tuberculosis (bTB) is a major world-wide health problem that has been difficult to control, due to the lack of an effective vaccine and limited ability of the tuberculin skin test (TST) and the ancillary whole blood interferon-gamma (IFN-gamma) release assay (IGRA) to detect all infected animals. A 6 h cytokine flow cytometric IFN-gamma (CFC) assay was developed in effort to overcome these limitations and expand methods for studying the mechanisms of bTB immunopathogenesis. The present study was conducted to evaluate IL-1 beta as a biomarker to use in conjunction with the IFN-gamma CFC assay to improve the diagnostic accuracy for bTB. Three animal groups with predefined Mbv infection status were used for analysis of IL-1 beta in plasma from whole blood cultures stimulated with ESAT-6/CFP-10 for 20-24 h. Parallel stimulations were performed for enumeration of IFN-gamma producing T cells. Data analysis showed that Mbv infected animals have a higher frequency of IFN-gamma producing CD4(+) T cells and plasma IL-1 beta than animals exposed to non-tuberculous mycobacteria (NTM) or uninfected control animals, with a significant correlation between the two readouts, thus allowing differentiation between the three animal groups. IL-1 beta has the potential to serve as an additional biomarker for detecting cattle infected with Mbv. (C) 2017 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available